310 related articles for article (PubMed ID: 27624963)
61. Advancing Homogeneous Antimicrobial Glycoconjugate Vaccines.
Adamo R
Acc Chem Res; 2017 May; 50(5):1270-1279. PubMed ID: 28463499
[TBL] [Abstract][Full Text] [Related]
62. A Murine, Bispecific Monoclonal Antibody Simultaneously Recognizing β-Glucan and MP65 Determinants in Candida Species.
Zito A; Bromuro C; Mandili G; Chiani P; Horenstein AL; Malavasi F; Cauda R; Cassone A; Torosantucci A
PLoS One; 2016; 11(2):e0148714. PubMed ID: 26859561
[TBL] [Abstract][Full Text] [Related]
63. Developing a vaccine against aspergillosis.
Stevens DA; Clemons KV; Liu M
Med Mycol; 2011 Apr; 49 Suppl 1():S170-6. PubMed ID: 20608783
[TBL] [Abstract][Full Text] [Related]
64. Testing Antifungal Vaccines in an Animal Model of Invasive Candidiasis and in Human Mucosal Candidiasis.
Segal E
Methods Mol Biol; 2017; 1625():343-353. PubMed ID: 28585001
[TBL] [Abstract][Full Text] [Related]
65. Effect of Candida albicans cell wall glucan as adjuvant for induction of autoimmune arthritis in mice.
Hida S; Miura NN; Adachi Y; Ohno N
J Autoimmun; 2005 Sep; 25(2):93-101. PubMed ID: 16242302
[TBL] [Abstract][Full Text] [Related]
66. A novel Th cell epitope of Candida albicans mediates protection from fungal infection.
Bär E; Gladiator A; Bastidas S; Roschitzki B; Acha-Orbea H; Oxenius A; LeibundGut-Landmann S
J Immunol; 2012 Jun; 188(11):5636-43. PubMed ID: 22529294
[TBL] [Abstract][Full Text] [Related]
67. An anti-inflammatory property of Candida albicans β-glucan: Induction of high levels of interleukin-1 receptor antagonist via a Dectin-1/CR3 independent mechanism.
Smeekens SP; Gresnigt MS; Becker KL; Cheng SC; Netea SA; Jacobs L; Jansen T; van de Veerdonk FL; Williams DL; Joosten LA; Dinarello CA; Netea MG
Cytokine; 2015 Feb; 71(2):215-22. PubMed ID: 25461401
[TBL] [Abstract][Full Text] [Related]
68. Glucan-like synthetic oligosaccharides: iterative synthesis of linear oligo-beta-(1,3)-glucans and immunostimulatory effects.
Jamois F; Ferrières V; Guégan JP; Yvin JC; Plusquellec D; Vetvicka V
Glycobiology; 2005 Apr; 15(4):393-407. PubMed ID: 15590774
[TBL] [Abstract][Full Text] [Related]
69. Candida antigens and immune responses: implications for a vaccine.
Moragues MD; Rementeria A; Sevilla MJ; Eraso E; Quindos G
Expert Rev Vaccines; 2014 Aug; 13(8):1001-12. PubMed ID: 24957934
[TBL] [Abstract][Full Text] [Related]
70. Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine.
Slovin SF; Ragupathi G; Musselli C; Olkiewicz K; Verbel D; Kuduk SD; Schwarz JB; Sames D; Danishefsky S; Livingston PO; Scher HI
J Clin Oncol; 2003 Dec; 21(23):4292-8. PubMed ID: 14645418
[TBL] [Abstract][Full Text] [Related]
71. Specific immune response to HBsAg is enhanced by beta-glucan oligosaccharide containing an alpha-(1-->3)-linked bond and biased towards M2/Th2.
Dong SF; Chen JM; Zhang W; Sun SH; Wang J; Gu JX; Boraschi D; Qu D
Int Immunopharmacol; 2007 Jun; 7(6):725-33. PubMed ID: 17466906
[TBL] [Abstract][Full Text] [Related]
72. Sequential Linkage of Carbohydrate Antigens to Mimic Capsular Polysaccharides: Toward Semisynthetic Glycoconjugate Vaccine Candidates against
Seco BMS; Xu FF; Grafmüller A; Kottari N; Pereira CL; Seeberger PH
ACS Chem Biol; 2020 Sep; 15(9):2395-2405. PubMed ID: 32835479
[TBL] [Abstract][Full Text] [Related]
73. Protective effect of antigen delivery using monoolein-based liposomes in experimental hematogenously disseminated candidiasis.
Carneiro C; Correia A; Lima T; Vilanova M; Pais C; Gomes AC; Real Oliveira MECD; Sampaio P
Acta Biomater; 2016 Jul; 39():133-145. PubMed ID: 27150234
[TBL] [Abstract][Full Text] [Related]
74. Polysaccharide-containing conjugate vaccines for fungal diseases.
Casadevall A; Pirofski LA
Trends Mol Med; 2006 Jan; 12(1):6-9. PubMed ID: 16309965
[TBL] [Abstract][Full Text] [Related]
75. Vaccination with mannan protects mice against systemic aspergillosis.
Liu M; Machová E; Neščáková Z; Medovarská I; Clemons KV; Martinez M; Chen V; Bystrický S; Stevens DA
Med Mycol; 2012 Nov; 50(8):818-28. PubMed ID: 22587733
[TBL] [Abstract][Full Text] [Related]
76. Involvement of branched units at position 6 in the reactivity of a unique variety of beta-D-glucan from Aureobasidium pullulans to antibodies in human sera.
Tada R; Tanioka A; Ishibashi K; Adachi Y; Tsubaki K; Ohno N
Biosci Biotechnol Biochem; 2009 Apr; 73(4):908-11. PubMed ID: 19352033
[TBL] [Abstract][Full Text] [Related]
77. Analysis of the titer and reactivity of antibody/ies against fungal cell wall β-glucans in human sera.
Ishibashi K; Morita M; Motoi M; Liu Y; Miura NN; Adachi Y; Ohno N
Int J Med Mushrooms; 2013; 15(2):115-26. PubMed ID: 23557364
[TBL] [Abstract][Full Text] [Related]
78. Effect of branched α-oligomannoside structures on induction of anti-Candida humoral immune response.
Paulovičová L; Paulovičová E; Karelin AA; Tsvetkov YE; Nifantiev NE; Bystrický S
Scand J Immunol; 2013 Jun; 77(6):431-41. PubMed ID: 23488735
[TBL] [Abstract][Full Text] [Related]
79. Preclinical studies on new proteins as carrier for glycoconjugate vaccines.
Tontini M; Romano MR; Proietti D; Balducci E; Micoli F; Balocchi C; Santini L; Masignani V; Berti F; Costantino P
Vaccine; 2016 Jul; 34(35):4235-4242. PubMed ID: 27317455
[TBL] [Abstract][Full Text] [Related]
80. Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis.
Xin H; Dziadek S; Bundle DR; Cutler JE
Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13526-31. PubMed ID: 18725625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
